Cargando…
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
BACKGROUND: Melanoma inhibitory activity (MIA) is a small secreted protein that interacts with extracellular matrix proteins. Its over-expression promotes the metastatic behavior of malignant melanoma, thus making it a potential prognostic marker in this disease. In the present study, the expression...
Autores principales: | El Fitori, Jamael, Kleeff, Jörg, Giese, Nathalia A, Guweidhi, Ahmed, Bosserhoff, Anja K, Büchler, Markus W, Friess, Helmut |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551595/ https://www.ncbi.nlm.nih.gov/pubmed/15710044 http://dx.doi.org/10.1186/1475-2867-5-3 |
Ejemplares similares
-
Effects of STI571 (gleevec) on pancreatic cancer cell growth
por: Li, Junsheng, et al.
Publicado: (2003) -
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
por: Li, Junsheng, et al.
Publicado: (2005) -
Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition
por: Schmidt, Jennifer, et al.
Publicado: (2012) -
Autoimmune Pancreatocholangitis, Non-Autoimmune Pancreatitis and Primary Sclerosing Cholangitis: A Comparative Morphological and Immunological Analysis
por: Esposito, Irene, et al.
Publicado: (2008) -
BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion
por: Kayed, Hany, et al.
Publicado: (2007)